Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug for the Prevention and Treatment of Symptoms of Pulmonary Complications in Patients With Coronavirus Infection (SARS-COVID-19)

NCT04346693 is registered in ClinicalTrials.gov with Burnasyan Federal Medical Biophysical Center as lead sponsor.

NCT NCT04346693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04346693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug for the Prevention and Treatment of Symptoms of Pulmonary Complications in Patients With Coronavirus Infection (SARS-COVID-19)
Lead sponsor
Burnasyan Federal Medical Biophysical Center
Phase
Phase 3
Overall status
Completed
Start date
April 8, 2020
Completion date
November 20, 2020
Enrollment
320 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory insufficiency, acute respiratory tract infection, hypoxemia, pneumonia, septic shock